Patents by Inventor Jeffrey J. Tarrand

Jeffrey J. Tarrand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10646574
    Abstract: Provided herein are compositions and methods for preparing intraarticular formulations comprising biocompatible pharmaceutical agents and use thereof in the treatment of diseases, such as degenerative bone diseases, including osteoarthritis of the knee, hip, or other joints, and similar chronic or acute destructive arthropathies resulting from autoimmune disorders or infectious disease.
    Type: Grant
    Filed: July 20, 2015
    Date of Patent: May 12, 2020
    Assignee: Board of Regents, The University of Texas System
    Inventors: Jeffrey J. Tarrand, Borje S. Andersson
  • Publication number: 20170209587
    Abstract: Provided herein are compositions and methods for preparing intraarticular formulations comprising biocompatible pharmaceutical agents and use thereof in the treatment of diseases, such as degenerative bone diseases, including osteoarthritis of the knee, hip, or other joints, and similar chronic or acute destructive arthropathies resulting from autoimmune disorders or infectious disease.
    Type: Application
    Filed: July 20, 2015
    Publication date: July 27, 2017
    Inventors: Jeffrey J. TARRAND, Borje S. ANDERSSON
  • Patent number: 8512724
    Abstract: The present invention provides antiseptic compositions that contain DMSO or DMA, an alcohol (e.g., isopropanol), and/or an additional antiseptic agent such as iodine. In certain embodiments, the antiseptic compositions may be used for skin disinfection and/or skin antisepsis (e.g., as applied via a swab).
    Type: Grant
    Filed: June 9, 2006
    Date of Patent: August 20, 2013
    Assignee: The Board of Regents of the University of Texas System
    Inventor: Jeffrey J. Tarrand
  • Publication number: 20090162301
    Abstract: The present invention provides antiseptic compositions that contain DMSO or DMA, an alcohol (e.g., isopropanol), and/or an additional antiseptic agent such as iodine. In certain embodiments, the antiseptic compositions may be used for skin disinfection and/or skin antisepsis (e.g., as applied via a swab).
    Type: Application
    Filed: June 9, 2006
    Publication date: June 25, 2009
    Inventor: Jeffrey J. Tarrand
  • Patent number: 6444872
    Abstract: A model of systemic mold/Aspergillus infection in a profoundly immunocompromised host has been established in the beagle dog. The beagle was rendered immunosuppressed using a combination of total body irradiation and daily steroids, which provided a window of time where the mold could be successfully inoculated through a bronchoscope. This created a localized infection in one lung lobe, which subsequently spread diffusely throughout the lung parenchyma, and uniformly resulted in the animal's death. The invention contemplates the further study of the pathophysiology of opportunistic mold infections in vivo and also provides examples for the development of new antifungal agents and more effective combinations of agents. Finally, the invention contemplates the development of technology for the early detection of systemic mold infections.
    Type: Grant
    Filed: August 18, 2000
    Date of Patent: September 3, 2002
    Assignee: Board of Regents, The University of Texas System
    Inventors: Borje S. Andersson, Taraneh K. Sadeghi, Douglas M. Cromeens, Jeffrey J. Tarrand